Highland, IN, United States of America

Anne M Robinson

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator in Medical Treatment: Anne M Robinson

Introduction: Anne M Robinson, based in Highland, IN, is a notable inventor recognized for her contributions to the medical field. With a focus on treating chronic conditions, her innovative approaches have the potential to impact countless lives.

Latest Patents: Robinson holds a patent for "Methods of treating Crohn's disease and ulcerative colitis." This patent details methods utilizing a JAK1 inhibitor to induce clinical remission and endoscopic improvement in patients with Crohn's disease. The patent outlines an initial induction dose followed by maintenance doses of the JAK1 inhibitor. Additionally, her methods extend to treating ulcerative colitis, showcasing her commitment to advancing therapeutic options for inflammatory bowel diseases.

Career Highlights: In her professional journey, Anne M Robinson has made significant strides in medical research. She is associated with AbbVie Inc., a leading biopharmaceutical company, where she continues to develop innovative treatment methods. Her work not only reflects her expertise but also her dedication to improving patient outcomes.

Collaborations: Throughout her career, Robinson has collaborated with distinguished colleagues such as Aileen L Pangan and Roopal B Thakkar. These partnerships enhance her research endeavors and contribute to the shared goal of advancing healthcare solutions.

Conclusion: Anne M Robinson exemplifies the spirit of innovation in medicine with her patent on treating Crohn's disease and ulcerative colitis. Her work at AbbVie Inc. and collaborations with esteemed colleagues further underscores her role as a leading inventor in the field. As her research progresses, the potential for breakthrough treatments remains a hopeful prospect for patients and the medical community alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…